Novartis AG (NVS) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - General secteur d'activité. Le siège social de l'entreprise est situé à Basel, Switzerland. Le PDG actuel est Vasant Narasimhan.
NVS a date d'introduction en bourse 1996-11-07, 75,883 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $296.06B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets a broad portfolio of prescription medicines and healthcare products worldwide. The company operates through two primary segments: Innovative Medicines, which focuses on specialty pharmaceuticals across therapeutic areas including oncology, immunology, neuroscience, ophthalmology, cardiovascular, and respiratory diseases, and Sandoz, a leading generics and biosimilars business that produces small molecule pharmaceuticals, active pharmaceutical ingredients, and biotechnology-based products. Novartis maintains strategic partnerships and collaborations with biotechnology companies to advance its clinical pipeline and expand treatment options for patients globally.
